MYOPIA CONTROL Therapy

Myopia is near-sightedness. It means that a child has difficulty seeing things at a distance (Example: Chalkboard).Early intervention is CRITICAL to managing a progressive condition such as myopia. while there is no minimum age to begin therapy, better outcomes are witnessed with early intervention. treatment slows the progression.

• Myopia can affect a child's ability to perform effectively in school.
• Myopia worsens with close work such as reading, drawing and screen time on computers, smart phones, tablets.
• Myopia worsens as children grow. Left without intervention, it can increase exponentially in teen years.
• Myopia increases the risk of serious visual complications such as retinal detachment, cataracts, macular degeneration and glaucoma in adulthood.
• Myopia is hereditary. A child with 1 near-sighted parent has 3 times the risk of developing myopia. This risk doubles to 6 times if both parents are near-sighted.
• Early and consistent therapeutic intervention is the only way to slow the progression of myopia.

How can Myopia be managed?

Listed below are few treatment options. However, a clinical evaluation of the extent of myopia and patient age will determine the combination best suited for your child.

Ortho-k lenses
A gentle, non-surgical solution that uses custom fit reshaping contact lenses that reduce the effect of myopia with continuous overnight wear. The lenses act as a "retainer" for the eyes, similar to a dental retainer worn overnight to align teeth. Once removed in the morning, your child’s eyes naturally maintain their shape for clear vision all day, without the need for daytime contacts or glasses.

MiSight lenses
MiSight lenses correct nearsightedness and slow the progression of myopia in children by utilizing special ActivControl® technology designed with dual- focus treatment zones

Low Dose Atropine Therapy
Nightly Low Dose Atropine (LDA) slows the myopic progression by relaxing the anatomy of the eye. This therapy is typically prescribed in conjunction with the use of contact lenses.

ADVANCED TESTING LAB

RETINAL PHOTOGRAPHY

The Optomap, is state-of-the-art testing device that provides a set of enhanced ultra-widefield digital retinal images of your retina, within a few minutes. This screening method which entails getting high-resolution digital images of the inside of the eye, captures an image of more than 80% of your retina, and is especially important for individuals with a history of high blood pressure, diabetes, retinal diseases, or strong glasses prescriptions due to higher risk of retinal disorders such as Glaucoma.

Visual Field Testing

Visual field testing tests for horizontal and vertical range of peripheral vision. The test helps analyze the presence of potential blind spots which may be symptoms for a host of conditions ranging from eye diseases to brain disorders. For instance, Glaucoma-induced optic nerve damage is associated with a specific visual field defect. On the other hand, brain abnormalities such as those caused by tumors can be detected by a visual field test. Hence, this test s a critical test in the care regimen.

Optical Coherence Tomography Scans

An Optical Coherence Tomography scan (commonly referred to as an OCT scan) is the latest advancement in imaging technology. Similar to ultrasound, this diagnostic technique uses light rather than sound waves to achieve higher resolution pictures of the structural tissues of the back of the eye. A noninvasive, painless test, it works using light without radiation and is similar to a CT scan of the eye. And is essential for early diagnosis of Glaucoma, Macular Degeneration, Diabetic retinal disease and conditions such as retinal detachment.

OCULUS Keratograph for Dry Eye Testing

The OCULUS Keratograph® 5M is an advanced non-invasive device for corneal topography and dry eye analysis. It is a corneal topographer with a built-in real keratometer and a color camera optimized for external imaging providing high-definition color images and video of the eye. It helps examine the meibomian glands, non-invasive tear film break-up time and the tear meniscus height measurement and evaluates the lipid layer.